Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-20

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis

NCT01753869

Cystic Fibrosis

TERMINATED NA

Remotely Supervised Exercise for Adults With Cystic Fibrosis

NCT05173194

Cystic Fibrosis

COMPLETED NA

Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI

NCT03593434

Cystic Fibrosis

COMPLETED

Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis

NCT00850551

Cystic Fibrosis

COMPLETED NA

Effects of a Partially Supervised Conditioning Program in CF

NCT01744561

Cystic Fibrosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this project is to implement a clinical tool utilizing predictors of mortality for patients with Cystic Fibrosis (CF) on the waiting list to identify candidates that should present for urgent medical care and, if appropriate, will prompt clinicians to update a candidate's lung allocation score (LAS), the score used to prioritize lung transplant candidates for transplant by medical urgency, and avoid undetected decline. The clinical tool consists of home spirometry measures and patient reported outcomes that is completed weekly on a mobile application device used clinically to track spirometry.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Fibrosis Lung Transplant; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinical Tool (Mobile Spirometry and Survey)

All subjects enrolled will be placed into the clinical tool arm. The clinical tool is comprised of a mobile application based assessment of home spirometry and a survey measuring patient reported outcomes.

Group Type EXPERIMENTAL

Clinical Tool (Mobile Spirometry and Survey)

Intervention Type OTHER

The clinical tool is a combination of home spirometry measurements and a patient survey measuring patient reported outcomes including the Cystic Fibrosis Respiratory Symptom Diary (CFRSD) and Chronic Respiratory Infection Symptom Score (CRISS©), with permission from the Seattle Quality of Life Group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical Tool (Mobile Spirometry and Survey)

The clinical tool is a combination of home spirometry measurements and a patient survey measuring patient reported outcomes including the Cystic Fibrosis Respiratory Symptom Diary (CFRSD) and Chronic Respiratory Infection Symptom Score (CRISS©), with permission from the Seattle Quality of Life Group.

Intervention Type OTHER